Average Co-Inventor Count = 10.24
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Schering Corporation (6 from 1,829 patents)
18 patents:
1. 10233193 - Fused tricyclic heterocyclic compounds useful for treating HIV infection
2. 9624208 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
3. 9273040 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
4. 9227971 - Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
5. 8883801 - Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
6. 8703784 - Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin
7. 8609675 - Fused Tricyclic Compounds as novel mTOR inhibitors
8. 8591943 - Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
9. 8476278 - Thiazole Derivatives as protein kinase inhibitors
10. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11. 8293747 - Heterocyclic amide compounds as protein kinase inhibitors
12. 8278337 - Substituted pyridines that are JNK inhibitors
13. 7652020 - Compounds for the treatment of inflammatory disorders
14. 7576085 - Imidazopyrazines as cyclin dependent kinase inhibitors
15. 7557104 - Imidazopyrazines as protein kinase inhibitors